← Eichor
Condition: Muscle Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Muscle Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05126472rTMS for Postoperative Brain Tumor Patients
NA · 1 location(s) · Brian J.Gill · NCT07530536FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Phase 1/Phase 2 · 128 location(s) · University of Birmingham · NCT04625907Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer
NA · 8 location(s) · Tianjin Medical University Second Hospital · NCT07180212Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Phase N/A · 6 location(s) · University of Washington · NCT07225127Investigating the Role of Energy Balance Modification on Health Responses in Chronic Lymphocytic Leukaemia
NA · 1 location(s) · University of Surrey · NCT06379282Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer
Phase 2 · 3 location(s) · Tianjin Medical University Second Hospital · NCT07475403To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients Wi
Phase 1/Phase 2 · 6 location(s) · RemeGen Co., Ltd. · NCT06378242Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial
Phase N/A · 1 location(s) · OHSU Knight Cancer Institute · NCT07726602Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study
NA · 1 location(s) · University of Aarhus · NCT07339761A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.
Phase 3 · 1 location(s) · Yizhuo Zhang · NCT06836492Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-r
Phase 1 · 1 location(s) · First Affiliated Hospital of Chongqing Medical University · NCT06916494Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Pa
Phase 2 · 16 location(s) · Theralase® Technologies Inc. · NCT03945162Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT06840262Chemoablation for Low-Grade Bladder Cancer
Phase 2 · 1 location(s) · Ekaterina Laukhtina · NCT07019220Effect of Misoprostol on Fluid Deficit Volume in Hysteroscopic Myomectomy
Phase 4 · 1 location(s) · Northwestern University · NCT07286188Safety and Efficacy Study of Collagenase CNT201 Injection for Treatment of Dupuytren's Contracture
Phase 1/Phase 2 · 1 location(s) · CONNEXT · NCT07640425TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients
NA · 1 location(s) · Zhejiang University · NCT07480785Effects of Microbiological and Immunological Factors on the Lower Urinary Tract
Phase N/A · 1 location(s) · University of Zurich · NCT07494864Promoting Active Living Among People With Metastatic Breast Cancer
NA · 1 location(s) · University of Oklahoma · NCT07238023Acute Effects of Visual Feedback-Assisted Inspiratory Muscle Training After Lobectomy
NA · 1 location(s) · Hacettepe University · NCT07646288Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
Phase 1/Phase 2 · 59 location(s) · Janssen Research & Development, LLC · NCT05316155Localized Leiomyosarcoma Biomarker Protocol
Phase N/A · 3 location(s) · University of Michigan Rogel Cancer Center · NCT04925089Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Can
Phase 3 · 103 location(s) · Ferring Pharmaceuticals · NCT06510374Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invas
Phase 3 · 11 location(s) · Astellas Pharma Global Development, Inc. · NCT07566156Prehabilitation for Patients Undergoing Lung Cancer Surgery
NA · 1 location(s) · University of Melbourne · NCT06716437Evaluation of the Effectiveness and Safety of Laparoscopic Assisted Mastectomy With Preservation of Nipple and Areola, I
NA · 1 location(s) · Henan Cancer Hospital · NCT07037537Outpatient Laser Ablation of Recurrent Non-muscle Invasive Bladder Cancer
Phase N/A · 1 location(s) · Jørgen Bjerggaard Jensen · NCT05337397A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
Phase N/A · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07390617Metabolism, Circadian Rhythms and Ovarian Function
Phase N/A · 1 location(s) · University Hospital, Lille · NCT05007834
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.